Alder Biopharmaceuticals Inc (ALDR)

์ƒ์žฅ๊ฑฐ๋ž˜์†Œ: NASDAQ | ์‚ฐ์—…: ์˜์•ฝํ’ˆ

๊ธฐ์—…๊ฐœ์š”

์ถœ์ฒ˜: ์•ผํ›„ ํŒŒ์ด๋‚ธ์Šค
Alder BioPharmaceuticals, Inc.๋Š” ์ž„์ƒ ๋‹จ๊ณ„์˜ ์ƒ๋ฌผ ์•ฝ์ œ ํšŒ์‚ฌ๋กœ ์šด์˜๋ฉ๋‹ˆ๋‹ค. ๊ทธ๊ฒƒ์€ ๋ฏธ๊ตญ, ํ˜ธ์ฃผ ๋ฐ ์•„์ผ๋žœ๋“œ์˜ ํŽธ๋‘ํ†ต ๋ฐ ๊ธฐํƒ€ ์‹ฌ๊ฐํ•œ ์‹ ๊ฒฝ ํ•™์  ๋˜๋Š” ์—ผ์ฆ์„ฑ ์งˆํ™˜ ํ™˜์ž์˜ ์น˜๋ฃŒ ํŒจ๋Ÿฌ๋‹ค์ž„์„ ๋ณ€ํ™”์‹œํ‚ค๊ธฐ์œ„ํ•œ ์น˜๋ฃŒ ์šฉ ํ•ญ์ฒด๋ฅผ ๋ฐœ๊ฒฌ, ๊ฐœ๋ฐœ ๋ฐ ์ƒ์—…ํ™”ํ•ฉ๋‹ˆ๋‹ค. ์ด ํšŒ์‚ฌ์˜ ์ฃผ๋„ ์ค‘์ถ” ๋‹จ๊ณ„ ์ œํ’ˆ ํ›„๋ณด์ž ์ธ Eptinezumab์€ ์นผ์‹œํ† ๋‹Œ ์œ ์ „์ž ๊ด€๋ จ ํŽฉํƒ€์ด๋“œ๋ฅผ ์–ต์ œํ•˜๋Š” ๋‹จ์ผ ํด๋ก  ํ•ญ์ฒด๋กœ ํŽธ๋‘ํ†ต ์˜ˆ๋ฐฉ์„์œ„ํ•œ 3 ๋‹จ๊ณ„ ์ค‘์ถ”์  ์ธ ์‹œ๋„ ์ค‘์ž…๋‹ˆ๋‹ค. ์ œํ’ˆ ํ›„๋ณด ํŒŒ์ดํ”„ ๋ผ์ธ์—๋Š” ๋˜ํ•œ ๋‡Œํ•˜์ˆ˜์ฒด ์•„๋ฐ ๋‹ ๋ ˆ์ดํŠธ ์‚ฌ์ด ํด๋ผ ์ œ - ํ™œ์„ฑํ™” ํด๋ฆฌ ํŽฉํƒ€์ด๋“œ -38์„ ํ‘œ์ ์œผ๋กœํ•˜๋Š” ์ „์ž„์ƒ ๋‹จํด๋ก  ํ•ญ์ฒด ALD1910; Clazakizumab์€ ์ „ ์—ผ์ฆ์„ฑ ์‚ฌ์ดํ†  ์นด์ธ ์ธ IL-6๋ฅผ ์ฐจ๋‹จํ•˜๊ธฐ ์œ„ํ•ด 2 ๋‹จ๊ณ„ 2b ์ž„์ƒ ์‹œํ—˜์„ ์™„๋ฃŒํ–ˆ๋‹ค. Alder BioPharmaceuticals, Inc.๋Š” 2002 ๋…„์— ์„ค๋ฆฝ๋˜์—ˆ์œผ๋ฉฐ ์›Œ์‹ฑํ„ด์— ์†Œ์žฌํ•œ Bothell์— ๋ณธ์‚ฌ๊ฐ€์žˆ๋‹ค.

A. ์ฃผ์š”์ง€ํ‘œ

ํŽ€๋”๋ฉ˜ํƒˆ

์ฃผ์š”์ง€ํ‘œ(TTM)
2017/Q3 2018/Q3
PER -2.79 -5.40
PBR 2.23 8.11
PCR -3.02 -6.08
PSR 1157.32 1209.62
์ฃผ๋‹น๋ฐฐ๋‹น๊ธˆ(๋‹ฌ๋Ÿฌ) 0.00 0.00
๋ฐฐ๋‹น์ˆ˜์ต๋ฅ (%) 0.00 0.00

Wonderful company at Fair price

โ€ป์•„๋ž˜ ์žฌ๋ฌด๋น„์œจ๊ณผ ์‚ฐ์—…ํ‰๊ท  ๊ฐ’์€ 2018๋…„ 3๋ถ„๊ธฐ ๊ธฐ์ค€ TTM(12๊ฐœ์›”) ๊ฐ’์ž…๋‹ˆ๋‹ค.
  • Wonderful company
์ˆ˜์ต์„ฑ & ์„ฑ์žฅ์„ฑ (2018๋…„ 3๋ถ„๊ธฐ ๊ธฐ์ค€)
๋™์ข…์‚ฐ์—…ํ‰๊ท 
ROE(%) -150.23 -78.14
ROIC(%) -149.94 -74.71
EPS์„ฑ์žฅ๋ฅ (%) 22.12 21.37
์•ˆ์ •์„ฑ (2018๋…„ 3๋ถ„๊ธฐ ๊ธฐ์ค€)
๋™์ข…์‚ฐ์—…ํ‰๊ท 
๋ถ€์ฑ„๋น„์œจ(%) 8.54 39.19
์ฐจ์ž…๊ธˆ์˜์กด๋น„์œจ(%) 0.00 1.53
์ด์ž๋ณด์ƒ๋น„์œจ NA -25.03
  • Fair Price
์ ์ •๊ฐ€๊ฒฉ์ง€ํ‘œ (2018๋…„ 3๋ถ„๊ธฐ ๊ธฐ์ค€)
๋™์ข…์‚ฐ์—…ํ‰๊ท 
PER -5.40 -5.93
PEG -5.56 -5.37
EV/EBIT -5.63 -5.34
EV/EBITDA -0.24 -0.32

B. ์žฌ๋ฌด์ œํ‘œ

์žฌ๋ฌด์ƒํƒœํ‘œ

(๋‹จ์œ„: 1000๋‹ฌ๋Ÿฌ)
2013 2014 2015 2016 2017
์ด์ž์‚ฐ 26,739 64,359 400,027 409,154 303,136
ํ˜„๊ธˆ๋ฐํ˜„๊ธˆ์„ฑ์ž์‚ฐ 23,227 46,795 206,492 116,216 76,896
๋งค์ถœ์ฑ„๊ถŒ 316 113 NA NA NA
์žฌ๊ณ ์ž์‚ฐ NA NA NA 936 NA
๋‹จ๊ธฐ๊ธˆ์œตํˆฌ์ž์ž์‚ฐ NA 9,077 98,680 235,651 199,344
๊ธฐํƒ€์œ ๋™์ž์‚ฐ 1,982 4,758 17,029 40,380 11,014
์ด์œ ๋™์ž์‚ฐ 25,525 60,743 322,201 393,183 287,254
์žฅ๊ธฐ๊ธˆ์œตํˆฌ์ž์ž์‚ฐ NA NA 75,840 865 222
์ˆœ์œ ํ˜•์ž์‚ฐ 1,214 1,160 1,974 7,076 5,630
๋ฌดํ˜•์ž์‚ฐ NA NA NA NA NA
์˜์—…๊ถŒ NA NA NA NA NA
์ด๋น„์œ ๋™์ž์‚ฐ 0 2,456 12 8,030 10,030
์ด๋ถ€์ฑ„ 58,727 5,202 12,510 26,371 23,861
๋งค์ž…์ฑ„๋ฌด 2,223 1,911 4,727 10,361 7,471
๋‹จ๊ธฐ์ฐจ์ž…๊ธˆ NA NA NA NA NA
๋ฏธ์ง€๊ธ‰๊ธˆ 2,128 2,963 7,583 15,437 15,803
๊ธฐํƒ€์œ ๋™๋ถ€์ฑ„ 18,717 135 62 92 92
์ด์œ ๋™๋ถ€์ฑ„ 23,068 5,009 12,372 25,890 23,366
์žฅ๊ธฐ์ฐจ์ž…๊ธˆ NA NA NA NA NA
๊ธฐํƒ€๋น„์œ ๋™๋ถ€์ฑ„ 35,659 193 138 481 495
์ด์ž๋ณธ -143,362 59,157 387,517 382,783 279,275
์ด์šฐ์„ ์ฃผ์ž๋ณธ๊ธˆ NA 0 0 0 NA
์ด๋ณดํ†ต์ฃผ์ž๋ณธ๊ธˆ -143,362 59,157 387,517 382,783 279,275
๋ณดํ†ต์ฃผ์ž๋ณธ๊ธˆ 2,443 196,085 610,394 761,461 946,876
์ด์ต์ž‰์—ฌ๊ธˆ -145,814 -136,906 -222,376 -378,630 -667,509
์ž์‚ฌ์ฃผ๋งค์ž… NA NA NA NA NA
๊ธฐํƒ€ํฌ๊ด„์†์ต๋ˆ„๊ณ„์•ก 9 -22 -501 -48 -92
๊ธฐํƒ€์ž๋ณธ NA NA NA NA NA
๋น„์ง€๋ฐฐ์ง€๋ถ„ NA NA NA NA NA

์†์ต๊ณ„์‚ฐ์„œ

(๋‹จ์œ„: 1000๋‹ฌ๋Ÿฌ)
2012 2013 2014 2015 2016 2017
์ด๋งค์ถœ 20,067 18,796 54,705 NA 113 1,619
๋งค์ถœ์›๊ฐ€ NA NA NA NA NA NA
๋งค์ถœ์ด์ด์ต 20,067 18,796 54,705 NA 113 1,619
๊ฐ๊ฐ€์ƒ๊ฐ๋น„ NA NA NA NA NA NA
ํŒ๋งค๊ด€๋ฆฌ๋น„ 37,886 39,557 45,901 86,329 157,971 292,623
์˜์—…์ด์ต -17,819 -20,761 8,804 -86,329 -157,858 -291,004
์ด์ž๋น„์šฉ 88 NA NA NA NA NA
๊ธฐํƒ€์ˆ˜์ต 13 148 104 859 1,789 2,768
๋ฒ•์ธ์„ธ๋น„์šฉ์ฐจ๊ฐ์ „์ด์ต -17,806 -20,613 8,908 -85,470 -156,069 -288,236
๋ฒ•์ธ์„ธ๋น„์šฉ NA NA NA NA NA NA
๋‹น๊ธฐ์ˆœ์ด์ต -17,806 -20,613 8,908 -85,470 -156,254 -288,879
๊ณ„์†์˜์—…์ด์ต -17,806 -20,613 8,908 -85,470 -156,254 -288,879
์ค‘๋‹จ์‚ฐ์—…์ด์ต NA NA NA NA NA NA
๋น„์ง€๋ฐฐ๋‹น๊ธฐ์ˆœ์ด์ต NA NA NA NA NA NA

ํ˜„๊ธˆํ๋ฆ„ํ‘œ

(๋‹จ์œ„: 1000๋‹ฌ๋Ÿฌ)
2012 2013 2014 2015 2016 2017
์˜์—…ํ™œ๋™ํ˜„๊ธˆํ๋ฆ„ -29,902 -36,132 -47,657 -81,233 -159,687 -226,617
๋‹น๊ธฐ์ˆœ์ด์ต -17,806 -20,613 8,908 -85,470 -156,254 -288,879
๋น„ํ˜„๊ธˆ์กฐ์ • 577 618 1,252 6,156 13,499 22,974
๊ฐ๊ฐ€์ƒ๊ฐ 1,042 935 701 751 1,674 3,001
์šด์ „์ž๋ณธ์ฆ๊ฐ -13,715 -17,072 -58,518 -2,670 -18,606 36,287
์ด์ž์ง€๊ธ‰ NA NA NA NA NA NA
์ด์ž์ˆ˜์ทจ NA NA NA NA NA NA
๋ฒ•์ธ์„ธ๋‚ฉ๋ถ€์•ก NA NA NA NA NA NA
๋Œ€์†์ถฉ๋‹น๊ธˆ NA NA NA NA NA NA
ํˆฌ์žํ™œ๋™ํ˜„๊ธˆํ๋ฆ„ -1,507 5,546 -9,734 -167,267 -67,720 34,380
์œ ํ˜•์ž์‚ฐ์ฒ˜๋ถ„ NA NA NA NA 5 NA
ํˆฌ์ž์ƒํ’ˆ์ฒ˜๋ถ„ 7,549 5,620 1,960 19,585 104,765 341,970
์œ ํ˜•์ž์‚ฐ์ทจ๋“ -1,031 -193 -649 -1,223 -6,619 -2,050
ํˆฌ์ž์ƒํ’ˆ์ทจ๋“ -8,025 NA -11,045 -185,629 -165,871 -305,540
๊ธฐํƒ€ํˆฌ์žํ™œ๋™ 0 119 0 0 0 0
์žฌ๋ฌดํ™œ๋™ํ˜„๊ธˆํ๋ฆ„ 37,905 48 80,982 408,206 137,110 162,917
์ฃผ์‹๋ฐœํ–‰ 48 48 81,018 408,170 137,110 162,917
์‚ฌ์ฑ„๋ฐœํ–‰ NA NA 36 NA NA NA
์ฃผ์‹์ทจ๋“ NA NA NA NA NA NA
๋ถ€์ฑ„์ƒํ™˜ NA NA NA -36 NA NA
๋ฐฐ๋‹น๊ธ‰์ง€๊ธ‰ NA NA NA NA NA NA
๊ธฐํƒ€์žฌ๋ฌดํ™œ๋™ NA NA NA NA NA NA
์™ธํ™”ํ™˜์ƒ์œผ๋กœ์ธํ•œํ˜„๊ธˆ์˜๋ณ€๋™ -3 12 -23 NA NA NA
ํ˜„๊ธˆ์˜์ฆ๊ฐ 6,493 -30,526 23,568 159,706 -90,297 -29,320

C. ๋‚ด๋ถ€/๊ธฐ๊ด€ํˆฌ์ž์ž

๋‚ด๋ถ€์ž ๊ฑฐ๋ž˜๋‚ด์—ญ

๊ธฐ๊ด€ํˆฌ์ž์ž

D. ๋‰ด์Šค

โ€ป2018๋…„ 12์›” 1์ผ ๊ธฐ์ค€ ์ตœ๊ทผ 15๊ฐœ์˜ ๋‰ด์Šค๋ฅผ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.
๋‚ ์งœ ์ œ๋ชฉ summary url
2018-11-29 Alder Biopharmaceuticals Inc.์— ๋Œ€ํ•œ IHS Markit Score ๋ณด๊ณ ์„œ์— ๋Œ€ํ•œ ์˜๊ฒฌ์„ ํ™•์ธํ•˜์‹ญ์‹œ์˜ค. Alder Biopharmaceuticals Inc ๋‚˜์Šค๋‹ฅ NMS : ALDR https://finance.yahoo.com/news/see-ihs-markit-score-report-130636748.html?.tsrc=rss
2018-11-20 ALDR ์‹ค์ ๋ณด๊ณ  ์ „ํ™” ๋˜๋Š” ํ”„๋ฆฌ์   ํ…Œ์ด์…˜์˜ ์‚ฌ๋ณธ 5-Nov-18 10:00 pm GMT Q3 2018 Alder Biopharmaceuticals Inc ์ˆ˜์ž… ๋ฐœํ‘œ https://finance.yahoo.com/news/edited-transcript-aldr-earnings-conference-062527210.html?.tsrc=rss
2018-11-08 Alder BioPharmaceuticalsยฎ, 11 ์›” 2 ํšŒ ํˆฌ์ž์ž ์ปจํผ๋Ÿฐ์Šค ์ฐธ์„ BOTHELL, Wash., 2018 ๋…„ 11 ์›” 8 ์ผ - Alder BioPharmaceuticals, Inc. (NASDAQ : ALDR)๋Š” ์น˜๋ฃŒ๋ฅผ์œ„ํ•œ ์ƒˆ๋กœ์šด ์น˜๋ฃŒ ์šฉ ํ•ญ์ฒด ๊ฐœ๋ฐœ์— ์ฃผ๋ ฅํ•˜๋Š” ์ƒ๋ฌผ ์˜์•ฝ ํšŒ์‚ฌ์ž…๋‹ˆ๋‹ค. https://finance.yahoo.com/news/alder-biopharmaceuticals-present-two-upcoming-210500541.html?.tsrc=rss
2018-11-05 Alder BioPharmaceuticals : 3Q ์ˆ˜์ž… ์Šค๋ƒ… ์‚ฌ์ง„ ์›Œ์‹ฑํ„ด ์ฃผ ๋ณด์Šคํ„ด ์†Œ์žฌ์˜ ํ•œ ์ฃผ๋‹น ๊ธฐ์ค€์œผ๋กœ 91 ์„ผํŠธ์˜ ์†์‹ค์„ ๊ธฐ๋กํ–ˆ๋‹ค๊ณ ํ•œ๋‹ค. ๊ทธ ๊ฒฐ๊ณผ๋Š” ์›”์ŠคํŠธ๋ฆฌํŠธ์˜ ๊ธฐ๋Œ€๋ฅผ ๋›ฐ์–ด ๋„˜์—ˆ๋‹ค. Zacks Investment๊ฐ€ ์กฐ์‚ฌํ•œ 5 ๋ช…์˜ ์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ท  ์ถ”์ •์น˜ โ€ฆ https://finance.yahoo.com/news/alder-biopharmaceuticals-3q-earnings-snapshot-232027093.html?.tsrc=rss
2018-11-05 Alder BioPharmaceuticalsยฎ, 2018 ๋…„ ์ œ 3 ๋ถ„๊ธฐ ์žฌ๋ฌด ๋ฐ ๊ฒฝ์˜ ์‹ค์  ๋ฐœํ‘œ
  • 2019 ๋…„ 1 ๋ถ„๊ธฐ์— Biologics License Application (BLA) ์ œ์ถœ - - ์•ฝ๋ฌผ ๋™ํƒœ ํ•™์˜ ๊ธ์ •์  ์ธ ๊ฒฐ๊ณผ๋ฅผ ํฌํ•จํ•˜๋„๋ก BLA ์ œ์ถœ์„์œ„ํ•œ ๊ฒฌ๊ณ ํ•œ ์ œ์กฐ ํŒจํ‚ค์ง€.
https://finance.yahoo.com/news/alder-biopharmaceuticals-reports-third-quarter-210800583.html?.tsrc=rss
2018-10-29 Alder BioPharmaceuticalsยฎ, 2018 ๋…„ 3 ๋ถ„๊ธฐ ์žฌ๋ฌด ๋ฐ ์šด์˜ ๊ฒฐ๊ณผ ๋…ผ์˜๋ฅผ์œ„ํ•œ ์ปจํผ๋Ÿฐ์Šค ์ฝœ ๊ฐœ์ตœ BOTHELL, Wash., 2018 ๋…„ 10 ์›” 29 ์ผ - Alder BioPharmaceuticals, Inc. (NASDAQ : ALDR)๋Š” ์น˜๋ฃŒ๋ฅผ์œ„ํ•œ ์ƒˆ๋กœ์šด ์น˜๋ฃŒ ์šฉ ํ•ญ์ฒด ๊ฐœ๋ฐœ์— ์ฃผ๋ ฅํ•˜๋Š” ์ƒ๋ฌผ ์˜์•ฝ ํšŒ์‚ฌ์ž…๋‹ˆ๋‹ค. https://finance.yahoo.com/news/alder-biopharmaceuticals-host-conference-call-200500857.html?.tsrc=rss
2018-10-23 ๋ณด๊ณ ์„œ : Alder BioPharmaceuticals, DurECT, Mettler-Toledo International, Internap, ์ปค๋ฆฌ์–ด ๊ต์œก ๋ฐ ์ ‘๊ทผ ๋ฆฌ์†Œ์Šค์˜ ๊ทผ๋ณธ์ ์ธ ์ถ”์ง„๋ ฅ ํƒ๊ตฌ ๋‰ด ํ˜ธ๋ผ์ด์ฆŒ, ์ƒˆ๋กœ์šด ํŠธ๋ Œ๋“œ ๋ฐ ํ–ฅํ›„ ๊ฐœ๋ฐœ ๋‰ด์š•, 10 ์›” 23 ์ผ, 2018 - Fundamental Markets์€ ์˜ค๋Š˜ ์•„์นจ ์ผ์ฐ ๋ฐœํ‘œ ๋œ ์ƒˆ๋กœ์šด ๋…๋ฆฝ์  ์ธ ์—ฐ๊ตฌ ๋ณด๊ณ ์„œ์—์„œ ๋ชจ๋“  ํ˜„์žฌ ํˆฌ์ž์ž๋“ค์—๊ฒŒ ์ตœ์‹  ํ•ต์‹ฌ ๊ฒฐ๊ณผ๋ฅผ ๋ฐœํ‘œํ–ˆ์Šต๋‹ˆ๋‹ค. https://finance.yahoo.com/news/report-exploring-fundamental-drivers-behind-122000887.html?.tsrc=rss
2018-10-23 Alder BioPharmaceuticalsยฎ๋Š” Eptinezumab์— ๋Œ€ํ•œ ์•ฝ๋ฌผ ๋™๋“ฑ์„ฑ ๋น„๊ต ์—ฐ๊ตฌ์—์„œ ๊ธ์ •์  ๊ฒฐ๊ณผ ๋ฐœํ‘œ ํŽธ๋‘ํ†ต ์น˜๋ฃŒ๋ฅผ์œ„ํ•œ ์ƒˆ๋กœ์šด ์น˜๋ฃŒ ์šฉ ํ•ญ์ฒด ๊ฐœ๋ฐœ์— ์ฃผ๋ ฅํ•˜๋Š” ๋ฐ”์ด์˜ค ์ œ์•ฝ ํšŒ์‚ฌ ์ธ Alder Biopharmaceuticals, Inc (ALDR)๋Š” ์—กํ‹ดํ‹ด (Eptinezumab)๊ณผ ๊ทธ ์•ฝ๋ฌผ์— ๋Œ€ํ•œ ์ž„์ƒ ์  ๊ณต๊ธ‰์˜ ๋น„๊ต ๊ฐ€๋Šฅ์„ฑ ํ‰๊ฐ€๋ฅผ ์ง€์›ํ•˜๊ธฐ์œ„ํ•œ ๋น„๊ต ์•ฝ๋ฌผ ๋™ํƒœ ํ•™ (PK) ๊ณ„ํš๋œ ์ƒ์—… ๊ณต๊ธ‰. Eptinezumab์€ ์นผ์‹œํ† ๋‹Œ ์œ ์ „์ž ๊ด€๋ จ ํŽฉํƒ€์ด๋“œ (CGRP)๋ฅผ ๋ชฉํ‘œ๋กœํ•˜๋Š” ํŽธ๋‘ํ†ต ์˜ˆ๋ฐฉ์„์œ„ํ•œ ์•Œ๋” (Alder)์˜ ์„ ๋„ ์—ฐ๊ตฌ ์ œํ’ˆ ํ›„๋ณด์ž…๋‹ˆ๋‹ค. ์•Œ๋ฐ๋ฅด (Alder) ์ž„์‹œ ์˜๋ฃŒ ๋‹ด๋‹น๊ด€ ์ธ ์—๋ฆญ ์นดํ„ฐ (Eric Carter) ๋ฐ•์‚ฌ๋Š” โ€œPK ์—ฐ๊ตฌ๊ฐ€ ์—กํ‹ดํ‹ด (eptinezumab)์˜ ๋น„๊ต ๊ฐ€๋Šฅ์„ฑ์„ ์ž…์ฆํ•˜๋ ค๋Š” ์šฐ๋ฆฌ์˜ ๋ชฉํ‘œ๋ฅผ ๋‹ฌ์„ฑ ํ•œ ๊ฒƒ์„ ๊ธฐ์˜๊ฒŒ ์ƒ๊ฐํ•œ๋‹ค. https://finance.yahoo.com/news/alder-biopharmaceuticals-announces-positive-results-120000925.html?.tsrc=rss
2018-10-12 Zacks Analyst ๋ธ”๋กœ๊ทธ ํ•˜์ด๋ผ์ดํŠธ : Alder, Xenon, Spero ๋ฐ Trevena Zacks Analyst ๋ธ”๋กœ๊ทธ ํ•˜์ด๋ผ์ดํŠธ : Alder, Xenon, Spero ๋ฐ Trevena https://finance.yahoo.com/news/zacks-analyst-blog-highlights-alder-122712305.html?.tsrc=rss
2018-10-11 ๋ฒค์ฒ˜ ์บํ”ผํƒˆ ํŽ€๋”ฉ์—์„œ ๋ฒˆ์ฐฝํ•˜๋Š” 4 ๊ฐ€์ง€ ๊ฑด๊ฐ• ๊ด€๋ฆฌ ์ฃผ์‹ ๋ฏธ๊ตญ ๊ฑด๊ฐ• ๊ด€๋ฆฌ์— ๋Œ€ํ•œ ๊ตญ๋‚ด์™ธ ํˆฌ์ž์˜ ๊พธ์ค€ํ•œ ์œ ์ž…์œผ๋กœ ์ธํ•ด ๊ณต๊ฐ„ ํ™•๋ณด์— ๋งŽ์€ ๋„์›€์ด๋˜์—ˆ์Šต๋‹ˆ๋‹ค. https://finance.yahoo.com/news/4-healthcare-stocks-thriving-venture-132401713.html?.tsrc=rss
2018-10-05 Alder BioPharmaceuticalsยฎ ๋ณด๊ณ ์„œ๋Š” ๋‚˜์Šค๋‹ฅ ์ƒ์žฅ ๊ทœ์ • 5635 (c) (4) Alder BioPharmaceuticals, Inc. (ALDR)๋Š” Alder ์ด์‚ฌํšŒ์˜ ๋ณด์ƒ์œ„์›ํšŒ (Compensation Committee of Alder โ€™s Board of Directors)๊ฐ€ 40,000์ฃผ์˜ ์ฃผ์‹์„ ๊ตฌ๋งคํ•  ์ˆ˜์žˆ๋Š” ๋น„ ์ž๊ฒฉ ๋ถ€์—ฌ ์Šคํ†ก ์˜ต์…˜์„ ๋ถ€์—ฌํ–ˆ๋‹ค๊ณ ๋ณด๊ณ ํ–ˆ๋‹ค. 2018 ๋…„ 10 ์›” 1 ์ผ๋ถ€๋กœ Alder์˜ 2018 Inducement Award Plan์— ๋”ฐ๋ผ ์‹ ์ž… ์‚ฌ์›์—๊ฒŒ Alder์˜ ๋ณดํ†ต์ฃผ๋ฅผ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.์ด ์ฃผ์‹ ์˜ต์…˜์€ ๊ณ ์šฉ ๊ฐœ์‹œ์ผ๋กœ๋ถ€ํ„ฐ 1 ๋…„ ํ›„ ์˜ต์…˜์˜ ๊ทผ๊ฐ„์ด๋˜๋Š” ์ฃผ์‹์˜ 25 %์— ๋Œ€ํ•ด ํ™•์ • ๋  ๊ฒƒ์ด๋ฉฐ ๋‚˜๋จธ์ง€ 75 %๋Š” ์˜ต์…˜์˜ ๊ธฐ์ดˆ๊ฐ€๋˜๋Š” ์ฃผ์‹์€ ์ข…์—…์›์˜ ๊ณ ์šฉ ์‹œ์ž‘ ๋‚ ์งœ์˜ 1 ๋…„ ๊ธฐ๋…์ผ ์ดํ›„ 36 ๊ฐœ์›” ๋™์•ˆ ๊ท ๋“ฑ ํ•œ ์›”๋ณ„ ํ• ๋ถ€๋กœ ํ™•์ •๋˜๋ฉฐ ๊ฐ ์ข…๋ชฉ ๋ณ„ ๊ฐ€๋“ ๊ธฐ๊ฐ„ ๋™์•ˆ ์•Œ๋”์— ๋Œ€ํ•œ ์ข…์—…์›์˜ ์ง€์†์ ์ธ ๊ทผ๋ฌด๋ฅผ ์กฐ๊ฑด์œผ๋กœํ•ฉ๋‹ˆ๋‹ค. https://finance.yahoo.com/news/alder-biopharmaceuticals-reports-inducement-grant-200500739.html?.tsrc=rss
2018-10-01 ๋ธํƒ€ ๋“œ๋ก  : ๋ผ์ด๋” ์ปต : ๋ธํƒ€ ๋“œ๋ก ์˜ ์ „๋ฌธ ๊ธฐ์ˆ  (ISS & ๋ณด์•ˆ ์‚ฌ์—…๋ถ€) ๋ผ์ด๋” ์ปต : ๋ธํƒ€ ๋“œ๋ก ์˜ ์ „๋ฌธ์„ฑ (ISS ๋ฐ ๋ณด์•ˆ ๋ถ€๋ฌธ) Dardilly, 2018 ๋…„ 10 ์›” 1 ์ผ ์„ฑ๊ณต์ ์ธ ๊ตฌํ˜„ ๋ธํƒ€ ๋“œ๋ก  ํŒ€์ด 6 ์ผ๊ฐ„์˜ ๊ณผ์ œ๋ฅผ ์„ฑ๊ณต์ ์œผ๋กœ ์ˆ˜ํ–‰ ํ•œ ๊ฒƒ์€ ์ž๋ถ€์‹ฌ์„ ๊ฐ€์ง€๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค. https://finance.yahoo.com/news/delta-drone-ryder-cup-successful-091700003.html?.tsrc=rss

E. ๊ธฐํƒ€์žฌ๋ฌด๋น„์œจ

โ€ป์•„๋ž˜ ์žฌ๋ฌด๋น„์œจ์€ 2018๋…„ 3๋ถ„๊ธฐ ๊ธฐ์ค€ ๊ฐ’์ž…๋‹ˆ๋‹ค.
์ˆ˜์ต์„ฑ&์„ฑ์žฅ์„ฑ
ROA -0.13
๋งค์ถœ์„ฑ์žฅ๋ฅ  0.37
์„ธํ›„์ˆœ์˜์—…์ด์ต์„ฑ์žฅ๋ฅ  0.07
์ž‰์—ฌํ˜„๊ธˆํ๋ฆ„์„ฑ์žฅ๋ฅ  0.42
๋‹น๊ธฐ์ˆœ์ด์ต์„ฑ์žฅ๋ฅ  0.04
์•ˆ์ •์„ฑ
Debt_to_Nopat -3.78
Altmanzscore 1.16
์žฌ๋ฌด๋ ˆ๋ฒ„๋ฆฌ์ง€๋น„์œจ 0.66
์œ ๋™๋น„์œจ 2.28
ํšจ์œจ์„ฑ
์ด์ž์‚ฐํšŒ์ „์œจ 0.39
ํˆฌํ•˜์ž๋ณธํšŒ์ „์œจ 0.57
๋งค์ถœ์ฑ„๊ถŒํšŒ์ „์œจ 4.12
๋งค์ž…์ฑ„๋ฌดํšŒ์ „์œจ 7.36
์žฌ๊ณ ์ž์‚ฐํšŒ์ „์œจ 2.24

F. ์žฌ๋ฌด๋น„์œจ์„ค๋ช